Scientist for Content Marketing
Biocytogen
Scientist for Content Marketing
Biocytogen
Antibody discovery and preclinical CRO services
Biocytogen · Waltham, United States · Full-time · Posted 2026-08-03
Salary: USD 100,000–110,000
Workplace: on_site
Department: 0500 Marketing
The Scientist for Content Marketing is responsible for collaborating with internal teams and developing marketing content in a variety of forms. He/she should be familiar with writing for the web, email marketing, and blog strategy and execution. He/she will produce high-quality content to increase brand awareness, execute marketing campaigns, drive engagement, and support inbound lead generation. He/she will also contribute to offline marketing initiatives, especially event/tradeshow planning.
Job Responsibilities:
Scientific content generation (50-75% effort)
Conference planning/preparation (25-50% effort)
Medical Insurance
Dental Insurance
BIOCYTOGEN is an Equal Opportunity Employer. Employment opportunities at BIOCYTOGEN BOSTON CORP are based upon one’s qualifications and capabilities to perform the essential functions of a particular job. All employment opportunities are provided without regard to race, color religion, sex, national origin, ancestry, age, sexual orientation, gender identity and expression, veteran status, military status, disability, mental illness, genetic information, or any other characteristic protected by law. This Equal Employment Opportunity policy governs all aspects of employment, including, but not limited to, recruitment, hiring, selection, job assignment, promotions, transfers, compensation, discipline, termination, layoff, access to benefits and training, and all other conditions and privileges of employment.
Powered by Workable
Antibody discovery and preclinical CRO services
Biocytogen provides integrated solutions for antibody-based drug research and development, with two main divisions: BioMice for preclinical CRO services and antibody discovery/licensing. Its RenMice platforms (RenMab, RenLite, RenNano) generate fully human antibodies using Size-Unlimited and Precise Chromosome Engineering, backed by a large off-the-shelf antibody library from Project Integrum to streamline discovery. The company combines gene-edited humanized mouse models with an extensive antibody library in an end-to-end pipeline, differentiating itself by offering rapid progression from target to therapeutic antibody and co-development/licensing options. Its goal is to discover and develop antibody drugs for more than 1,000 targets and become a leading provider of antibody discovery and preclinical services.
Explore more opportunities at Biocytogen